{
  "id": "048c6dc067be7ede",
  "title": "Lexaria Bioscience Corp . Announces $3 . 5 Million Registered Direct Offering Priced At - the - Market Under Nasdaq Rules",
  "description": "20251215T171500Z",
  "content": "",
  "source": "dallassun.com",
  "source_url": "http://www.dallassun.com/news/278755878/lexaria-bioscience-corp-announces-35-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules",
  "published_at": "20251215T171500Z",
  "fetched_at": "2025-12-16T00:23:22.810654+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "http://www.dallassun.com/news/278755878/lexaria-bioscience-corp-announces-35-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules",
    "url_mobile": "",
    "title": "Lexaria Bioscience Corp . Announces $3 . 5 Million Registered Direct Offering Priced At - the - Market Under Nasdaq Rules",
    "seendate": "20251215T171500Z",
    "socialimage": "",
    "domain": "dallassun.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}